Contemporary Management of Immune Checkpoint Inhibitor-related Adverse Events.
2/5 보강
OpenAlex 토픽 ·
Cancer Immunotherapy and Biomarkers
CAR-T cell therapy research
Multiple and Secondary Primary Cancers
Immune checkpoint inhibitors have become one of the pillars of cancer treatment, but may be associated with a wide range of potential adverse effects.
APA
Akshee Batra, Daniel Tuerff, Jose Lutzky (2026). Contemporary Management of Immune Checkpoint Inhibitor-related Adverse Events.. Surgical oncology clinics of North America, 35(2), 415-432. https://doi.org/10.1016/j.soc.2025.10.010
MLA
Akshee Batra, et al.. "Contemporary Management of Immune Checkpoint Inhibitor-related Adverse Events.." Surgical oncology clinics of North America, vol. 35, no. 2, 2026, pp. 415-432.
PMID
41903997 ↗
Abstract 한글 요약
Immune checkpoint inhibitors have become one of the pillars of cancer treatment, but may be associated with a wide range of potential adverse effects. In this review, we discuss the presentation and management of immune-related adverse events according to their severity and organ system involvement. Tables with management guidelines are included.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (1)
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.